102 related articles for article (PubMed ID: 19565912)
1. Delivery of phosphorodiamidate morpholino antisense oligomers in cancer cells.
Devi GR
Methods Mol Biol; 2009; 542():351-61. PubMed ID: 19565912
[TBL] [Abstract][Full Text] [Related]
2. Cellular uptake of neutral phosphorodiamidate morpholino oligomers.
Iversen PL; Aird KM; Wu R; Morse MM; Devi GR
Curr Pharm Biotechnol; 2009 Sep; 10(6):579-88. PubMed ID: 19619124
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.
Ko YJ; Devi GR; London CA; Kayas A; Reddy MT; Iversen PL; Bubley GJ; Balk SP
J Urol; 2004 Sep; 172(3):1140-4. PubMed ID: 15311058
[TBL] [Abstract][Full Text] [Related]
4. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.
Tilley LD; Hine OS; Kellogg JA; Hassinger JN; Weller DD; Iversen PL; Geller BL
Antimicrob Agents Chemother; 2006 Aug; 50(8):2789-96. PubMed ID: 16870773
[TBL] [Abstract][Full Text] [Related]
5. Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.
Geller BL; Deere J; Tilley L; Iversen PL
J Antimicrob Chemother; 2005 Jun; 55(6):983-8. PubMed ID: 15872045
[TBL] [Abstract][Full Text] [Related]
6. Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers.
Ghosh C; Iversen PL
Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):263-74. PubMed ID: 10984120
[TBL] [Abstract][Full Text] [Related]
7. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.
Deere J; Iversen P; Geller BL
Antimicrob Agents Chemother; 2005 Jan; 49(1):249-55. PubMed ID: 15616302
[TBL] [Abstract][Full Text] [Related]
8. HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers.
Moulton HM; Hase MC; Smith KM; Iversen PL
Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):31-43. PubMed ID: 12691534
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers.
Amantana A; Iversen PL
Curr Opin Pharmacol; 2005 Oct; 5(5):550-5. PubMed ID: 16087398
[TBL] [Abstract][Full Text] [Related]
10. In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors.
Devi GR; Beer TM; Corless CL; Arora V; Weller DL; Iversen PL
Clin Cancer Res; 2005 May; 11(10):3930-8. PubMed ID: 15897595
[TBL] [Abstract][Full Text] [Related]
11. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
Nelson MH; Stein DA; Kroeker AD; Hatlevig SA; Iversen PL; Moulton HM
Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
[TBL] [Abstract][Full Text] [Related]
12. Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing.
Marshall NB; Oda SK; London CA; Moulton HM; Iversen PL; Kerkvliet NI; Mourich DV
J Immunol Methods; 2007 Aug; 325(1-2):114-26. PubMed ID: 17673254
[TBL] [Abstract][Full Text] [Related]
13. Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds.
Nan Y; Zhang YJ
Front Microbiol; 2018; 9():750. PubMed ID: 29731743
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on antisense therapy for the prevention of restenosis.
Kipshidze N; Moses J; Shankar LR; Leon M
Curr Opin Mol Ther; 2001 Jun; 3(3):265-77. PubMed ID: 11497351
[TBL] [Abstract][Full Text] [Related]
15. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Validation of Phosphorodiamidate Morpholino Oligomers.
Aung-Htut MT; McIntosh CS; West KA; Fletcher S; Wilton SD
Molecules; 2019 Aug; 24(16):. PubMed ID: 31408997
[TBL] [Abstract][Full Text] [Related]
17. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
Tilley LD; Mellbye BL; Puckett SE; Iversen PL; Geller BL
J Antimicrob Chemother; 2007 Jan; 59(1):66-73. PubMed ID: 17079242
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.
Geller BL; Deere JD; Stein DA; Kroeker AD; Moulton HM; Iversen PL
Antimicrob Agents Chemother; 2003 Oct; 47(10):3233-9. PubMed ID: 14506035
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptide-conjugated morpholino oligomers.
Alonso M; Stein DA; Thomann E; Moulton HM; Leong JC; Iversen P; Mourich DV
J Fish Dis; 2005 Jul; 28(7):399-410. PubMed ID: 16083445
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Phosphorodiamidate Morpholino Oligonucleotides and Their Chimeras Using Phosphoramidite Chemistry.
Paul S; Caruthers MH
J Am Chem Soc; 2016 Dec; 138(48):15663-15672. PubMed ID: 27934012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]